Why do you see this as speculative stock?
Profitable, sound growth (without the clinical results of the big trial), excellent reports from various centers around the world, a large part of the stock is owned by institutions and reasonably stable holdings. Good volume recently.
The only Q is the price - is it worth a PE of 33?
If you extrapolate the current profits figures, based on a dose sales increase of 25% PA then what would you see as the profit number say in 2015?
Many companies with a sold 25% PA increase in sales would trade at or above a PE of 30. So if you think they can make the 25% PA then it is a punt on the trial results.
However if you believe 25% is achievable then the trial results would be a big bonus. maybe :-)
At 25% compound they hit 30,000 doses PA in 7 years. What will be interesting is the 2nd quarter dose numbers, in Jan 2013. If SRX massaged the 1st quarter numbers to get an easy ride at the AGM then the emperor will be naked. If they can continue with numbers like the last quarter (37%) then watch the share price then.
Be lucky.
PS at 37% growth they hit 30,000 in year 5.
What price the shares.
- Forums
- ASX - By Stock
- Ann: Clinical Study Result
Why do you see this as speculative stock?Profitable, sound...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRX (ASX) to my watchlist
|
|||||
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M |
Open | High | Low | Value | Volume |
17.5¢ | 17.5¢ | 17.5¢ | $1.581K | 9.037K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 2528552 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 2095603 | 36 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 2528552 | 0.175 |
8 | 3657688 | 0.170 |
1 | 18186 | 0.165 |
1 | 11500 | 0.155 |
1 | 2577 | 0.097 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 2095103 | 35 |
0.185 | 103336 | 7 |
0.190 | 161199 | 7 |
0.195 | 520478 | 3 |
0.200 | 533237 | 9 |
Last trade - 10.49am 15/08/2024 (20 minute delay) ? |
Featured News
SRX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online